Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Multiple cellular macromolecules in microbes refers to the collective set of essential biological components—including proteins, lipids, and nucleic acids—that serve as the site of action for broad-spectrum antimicrobial agents (DrugBank, 2024). Unlike selective antibiotics that target a single enzyme or pathway, these agents exert their effects through non-specific chemical or physical interactions that disrupt the structural and functional integrity of the microbe (CDC, 2008). Common mechanisms include the denaturation of structural and enzymatic proteins, the dissolution or disruption of lipid bilayers in cell membranes, and the chemical modification (e.g., oxidation or alkylation) of DNA and RNA (StatPearls, 2023). This multi-target approach is the hallmark of antiseptics, disinfectants, and sterilants, providing a rapid and potent microbicidal effect against a wide range of bacteria, viruses, and fungi (NCBI, 2021). Because these agents attack numerous vital components simultaneously, the development of high-level microbial resistance is significantly less common than with site-specific drugs (PubMed, 2019). However, the lack of specificity also means these agents can be toxic to host tissues, generally restricting their clinical use to topical applications, wound care, or the sterilization of inanimate surfaces and medical instruments (PubChem, 2024).
Broad-spectrum destruction of microbial components via protein denaturation, membrane lysis, and chemical modification of nucleic acids (StatPearls, 2023; CDC, 2008).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple cellular macromolecules in microbes.